Does TISLELIZUMAB-JSGR Cause Off label use? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Off label use have been filed in association with TISLELIZUMAB-JSGR. This represents 18.0% of all adverse event reports for TISLELIZUMAB-JSGR.
9
Reports of Off label use with TISLELIZUMAB-JSGR
18.0%
of all TISLELIZUMAB-JSGR reports
2
Deaths
1
Hospitalizations
How Dangerous Is Off label use From TISLELIZUMAB-JSGR?
Of the 9 reports, 2 (22.2%) resulted in death, 1 (11.1%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB-JSGR. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB-JSGR Cause?
Disease progression (15)
Anaemia (8)
Pneumonia (8)
Lymphadenopathy (7)
Thrombocytopenia (7)
Infusion related reaction (6)
Pyrexia (6)
Death (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)